Member States defined their requirements according to the potentials /existence of their own PASS registers, for the summary see the Annex to GVP Module VIII. SÚKL defined the conditions in a way as to remain informed about all the studies conducted in the CZ.
Home
/
Medicines
/
Pharmacovigilance
/
Documents for pharmacovigilance branch
/
Questions and answers on the amended Act on...
/
PASS – Post-Authorisation Safety Studies
/
What are the Member States´ requirements for...